Team:MIT/Project
From 2013.igem.org
(Difference between revisions)
(6 intermediate revisions not shown) | |||
Line 16: | Line 16: | ||
<p> | <p> | ||
<div style="text-align:justify"> | <div style="text-align:justify"> | ||
- | The MIT iGEM team sought to create a new mode of engineered intercellular communication for use in synthetic biology by modifying the contents of existing exosomes through the use of naturally occurring miRNA and the protein domain Acyl-TyA. We built on existing research targeting proteins to exosomes to enable intercellular communication by targeting signal proteins into exosomes and into HEK 293 receiver cells. <br><br> | + | <h1>The Roadmap to Exosomal Cell-Cell Communication</h1> |
+ | The MIT iGEM team sought to create a new mode of engineered intercellular communication for use in synthetic biology by modifying the contents of existing exosomes through the use of naturally occurring miRNA and the protein domain Acyl-TyA. We built on existing research targeting proteins to exosomes to enable intercellular communication by targeting signal proteins into exosomes and into HEK 293 receiver cells.<br><br> | ||
+ | |||
+ | Over the summer, we accomplished the following: <br><br> | ||
<h3>(1) Exosomal Cell-Cell Communication with miRNA</h3> | <h3>(1) Exosomal Cell-Cell Communication with miRNA</h3> | ||
Line 40: | Line 43: | ||
We demonstrated retained functionality of our protein signal after fusion with Acyl-TyA (Acyl-TyA-rtTA3). In addition, we tested our reporter construct (TRE-tight_mkate), which allowed us to assay for the function of our protein signal.<br><br> | We demonstrated retained functionality of our protein signal after fusion with Acyl-TyA (Acyl-TyA-rtTA3). In addition, we tested our reporter construct (TRE-tight_mkate), which allowed us to assay for the function of our protein signal.<br><br> | ||
- | <h3>(8 | + | <h3>(8) Application - Endogenous Gene Activation</h3> |
- | + | Most regulated promoters in Synthetic Biology have been engineered to have upstream regulatory sites, but endogenous genes don't have such features. Activating an endogenous gene would require targeting an activator to an arbitrary sequence upstream of an endogenous promoter. Cas9 allows us to target arbitrary sequences using a guide RNA specific to that sequence. By fusing a VP16 domain to Cas9 we're able to create a programmable DNA binding trans-activator.<br><br> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | <h3>( | + | <h3>(9) Testing Cas9-VP16</h3> |
- | We tested our Cas9-VP16 fusion protein by transfecting it into HEK 293 cells along with a guide RNA which will target the Cas9-VP16 to our reporter construct and activate the expression of EYFP. We showed that our Cas9-VP16 fusion is indeed functional. <br><br> | + | We tested our Cas9-VP16 fusion protein by transfecting it into HEK 293 cells along with a guide RNA which will target the Cas9-VP16 to upstream regulatory sites on our reporter construct and activate the expression of EYFP. We showed that our Cas9-VP16 fusion is indeed functional. <br><br> |
- | <h3>( | + | <h3>(10) Future Work</h3> |
- | + | We currently have being constructed an Acyl-TyA-Cas9-VP16 fusion protein to send through exosomes to activate endogenous genes within receiver cells.<br><br> | |
Latest revision as of 03:57, 29 October 2013
The Roadmap to Exosomal Cell-Cell Communication
The MIT iGEM team sought to create a new mode of engineered intercellular communication for use in synthetic biology by modifying the contents of existing exosomes through the use of naturally occurring miRNA and the protein domain Acyl-TyA. We built on existing research targeting proteins to exosomes to enable intercellular communication by targeting signal proteins into exosomes and into HEK 293 receiver cells.Over the summer, we accomplished the following: